Epigenetic regulation as a new target for breast cancer therapy

Cancer Invest. 2007 Dec;25(8):659-65. doi: 10.1080/07357900701719234.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acetylation
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics*
  • Chromatin / chemistry
  • DNA Methylation
  • Epigenesis, Genetic*
  • Estrogen Receptor alpha / genetics
  • Estrogen Receptor alpha / physiology
  • Histone Deacetylase Inhibitors
  • Histones / metabolism
  • Humans
  • Hydroxamic Acids / therapeutic use
  • Receptors, Retinoic Acid / genetics
  • Receptors, Retinoic Acid / physiology
  • Vorinostat

Substances

  • Chromatin
  • Estrogen Receptor alpha
  • Histone Deacetylase Inhibitors
  • Histones
  • Hydroxamic Acids
  • Receptors, Retinoic Acid
  • retinoic acid receptor beta
  • Vorinostat